Health Journal Online

Tag: Showing

  • GLP-1 Drugs Like Ozempic Are Showing a 47 Percent Reduction in Breast Cancer Risk in a Major New Study — and Weight Loss May Not Explain It

    GLP-1 Drugs Like Ozempic Are Showing a 47 Percent Reduction in Breast Cancer Risk in a Major New Study — and Weight Loss May Not Explain It

    The list of conditions that GLP-1 receptor agonists appear to protect against keeps getting longer. These drugs — which include semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the newly approved orforglipron (Foundayo) — were originally developed for type 2 diabetes before emerging as transformative obesity medications. Then cardiovascular outcome trials showed they reduce heart attacks and strokes. Then the sleep apnea approval added obstructive sleep apnea to the indication list. Then studies suggested reductions in kidney disease progression, non-alcoholic fatty liver disease, and alcohol dependence.

    And now, a major study presented at the American Society of Clinical Oncology Annual Meeting in Chicago in early June 2026 and reported widely on June 10, 2026 has added breast cancer to the rapidly expanding list of conditions that GLP-1 drugs appear to protect against — with an effect magnitude that has stunned the oncology community.

    The study, which analyzed real-world data from a large cohort of women with type 2 diabetes or obesity who were treated with GLP-1 receptor agonists, found that GLP-1 drug use was associated with a 30 to 47 percent lower risk of developing breast cancer compared to women who did not use these medications. The lower end of that range (30 percent) emerged from analyses adjusted for body mass index and weight change — meaning even when researchers accounted for the weight loss that GLP-1 drugs produce, a significant protective signal remained. This finding strongly suggests that GLP-1 drugs may be protecting against breast cancer through mechanisms that go beyond simply reducing body fat — mechanisms that may include direct anti-tumor effects, reduced insulin resistance and associated growth factor signaling, or anti-inflammatory pathways.

    Why This Finding Is Biologically Plausible

    The biological connection between metabolic dysfunction, obesity, insulin resistance, and breast cancer risk is well established. Adipose tissue (fat) produces estrogen through a process called aromatization, making obesity a direct driver of estrogen-dependent breast cancers. Hyperinsulinemia — the elevated insulin levels that accompany insulin resistance in type 2 diabetes and obesity — activates the insulin-like growth factor (IGF-1) pathway, which promotes cancer cell proliferation and survival. Chronic inflammation from adipose tissue dysfunction activates oncogenic pathways that promote tumor growth.

    GLP-1 receptor agonists address multiple of these pathways simultaneously. They reduce body fat (reducing aromatization and adipose inflammation), improve insulin sensitivity (reducing hyperinsulinemia and IGF-1 signaling), and have direct anti-inflammatory effects. Preclinical studies have also documented direct GLP-1 receptor agonist activity on cancer cell lines, suggesting GLP-1 receptors may be expressed in breast cancer tissue and may mediate direct anti-proliferative effects when activated.

    The study’s finding that the protective signal persists even after adjustment for weight and BMI is the most provocative result, because it suggests the drug’s biological effects — beyond simple caloric restriction and fat mass reduction — are contributing to cancer protection.

    What This Means for the 15 Million Americans on GLP-1 Drugs

    Approximately 15 million Americans are currently prescribed GLP-1 receptor agonists. The vast majority are taking them for type 2 diabetes or weight management. If the breast cancer protective signal seen in this study is confirmed in larger prospective trials and in controlled analyses, it would represent an additional major health benefit of these medications — one that could influence prescribing decisions, insurance coverage arguments, and cancer prevention discussions.

    The researchers caution that this is observational data from a real-world cohort, not a randomized controlled trial. Confounding variables — the possibility that GLP-1 drug users differ from non-users in ways that independently affect breast cancer risk — must be accounted for before these findings can be considered definitive. Prospective studies and potential randomized trials with cancer outcomes as endpoints are now being planned. The Phase 3 ORCA trial of semaglutide in high-risk cancer prevention populations is one ongoing effort that will provide higher-quality evidence.

    For women currently taking GLP-1 drugs for any indication, this study is not a recommendation to take them as cancer prevention without diabetes or obesity indication — rather, it is an important signal that the health benefits of these medications may be broader than previously understood.

    Frequently Asked Questions

    Q: What did the new GLP-1 and breast cancer study find?

    A: A real-world cohort study presented at ASCO 2026 found that women with type 2 diabetes or obesity who used GLP-1 receptor agonists had a 30–47% lower breast cancer risk compared to non-users. The effect persisted after adjustment for weight loss.

    Q: Does this mean women should take GLP-1 drugs specifically to prevent breast cancer?

    A: No. This is observational data, not a randomized trial. The finding is a promising signal that warrants further research, not a clinical recommendation for GLP-1 drugs as cancer prevention outside of established indications.

    Q: Why might GLP-1 drugs protect against breast cancer beyond weight loss?

    A: By reducing hyperinsulinemia, improving insulin sensitivity (lowering IGF-1 signaling), reducing adipose-tissue inflammation, and potentially through direct GLP-1 receptor activity on breast tissue — all mechanisms independent of weight loss.

    Q: Which GLP-1 drugs were included in the study?

    A: The study analyzed GLP-1 receptor agonist use broadly, including semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) among the most commonly used agents. Results were not limited to a specific drug within the class.

    Q: How does this new finding fit with the other cancer data on GLP-1 drugs?

    A: A 2024 Nature Medicine study documented lower incidence of multiple obesity-associated cancers in GLP-1 users. The 2026 ASCO breast cancer study adds specifically to that growing body of evidence suggesting GLP-1 drugs may have broad anti-cancer properties.

    Source link

  • New York City Reports First Severe Mpox Clade I Case — A More Dangerous Strain Now Showing Up Across America

    New York City Reports First Severe Mpox Clade I Case — A More Dangerous Strain Now Showing Up Across America

    New York City has confirmed its first case of mpox caused by clade I — the more dangerous variant of the virus — raising concern among public health officials as the more infectious and more severe form of mpox continues to arrive in major U.S. cities. The NYC Health Department issued a formal advisory noting that there is no known local community transmission tied to this case, but health commissioner Dr. Alister Martin confirmed the virus is now present in the city and urged residents to be aware of symptoms and vaccination options.

    As of May 9, 2026, the NYC Department of Health reported 79 mpox cases in New York City in 2026 alone, including at least a small number of clade I cases. Nationally, the CDC confirmed more than 20 clade I mpox cases in the United States as of June 2026, all linked to recent international travel or contact with travelers from affected regions in Central and Eastern Africa or Western Europe.

    Clade I vs. Clade II: Why This Strain Is More Concerning

    Most Americans became familiar with mpox during the 2022 global outbreak, which was caused by clade II — a less severe form of the virus with a survival rate above 99.9%. Clade I is different. According to Fox News senior medical analyst Dr. Marc Siegel, “Clade I causes more severe symptoms and can be life-threatening.” In the ongoing outbreak in the Democratic Republic of the Congo, clade I has had a case fatality rate significantly higher than clade II. Complications can include severe skin lesions, pneumonia, brain inflammation, and bacterial superinfections.

    While clade I spreads through the same routes as clade II — primarily close physical contact, sexual contact, kissing, and contact with infected skin lesions or respiratory droplets at close range — it does not spread through casual airborne contact over long distances. The CDC has assessed the current risk to the general U.S. population as low, but characterizes the risk as low to moderate for men who have sex with men, who accounted for the majority of the 2022 U.S. outbreak.

    Who Should Get Vaccinated and What to Watch For

    The JYNNEOS vaccine, approved for mpox prevention, provides strong protection against both clade I and clade II. The CDC recommends the two-dose vaccine series for gay, bisexual, and other men who have sex with men aged 18 and older with specific risk factors. Anyone who traveled to or had contact with someone from the DRC, neighboring African countries, or parts of Western Europe reporting clade I cases should consult their healthcare provider immediately.

    Symptoms of mpox typically appear 3 to 17 days after exposure and begin with fever, swollen lymph nodes, muscle aches, and exhaustion, followed by a distinctive rash that progresses through several stages of fluid-filled lesions. Anyone with a new or unexplained rash — particularly after recent travel or close physical contact — should contact a healthcare provider, mention any travel history, and avoid close contact with others until evaluated. NYC offers free mpox vaccination at multiple locations across the five boroughs.

    The arrival of clade I mpox in New York City — the nation’s most densely populated metro area — is a reminder that the city’s international connectivity, while a source of enormous economic and cultural vitality, also serves as an entry point for emerging infectious diseases. Whether the public health infrastructure put in place after 2022 remains fully operational under reduced federal staffing is a question officials have not fully answered.

    Source link

  • Science Reveals Incredible Body Facts Showing What the Heart Blood and Lungs Do Every Moment

    Science Reveals Incredible Body Facts Showing What the Heart Blood and Lungs Do Every Moment

    Each day, the human body performs countless tasks that keep life going, many of which happen without awareness or effort. From the rhythmic beating of the heart to the constant flow of blood and the steady exchange of air in the lungs, these essential processes form the foundation of human survival.

    Together, they create a sophisticated system of blood circulation and lung function that fuels every muscle, organ, and cell with oxygen and nutrients.

    Science has uncovered astonishing details about these daily operations. Even at rest, the body’s internal machinery remains in motion, maintaining balance and energy through precise biological coordination. The heart, blood, and lungs serve as one of the most impressive examples of this teamwork.

    How the Heart Works Every Day

    The heart operates as the engine of the body’s circulatory system, pumping blood continuously to sustain all organs. On average, the heart beats about 100,000 times per day, moving nearly 7,500 liters of blood through arteries, veins, and capillaries.

    Each heartbeat is triggered by electrical impulses that direct contractions in a specific rhythm, an elegant pattern that allows oxygen-rich blood to reach every part of the body.

    The heart’s structure includes four chambers: two atria and two ventricles. The right side handles deoxygenated blood, sending it to the lungs for oxygenation, while the left side receives fresh oxygenated blood and pushes it through systemic circulation.

    It’s a process so efficient that the entire volume of blood in the body circulates roughly once per minute.

    Interestingly, emotional and physical states can momentarily influence heart rate. Feelings of stress or excitement activate the body’s sympathetic nervous system, increasing heartbeats, while calm or rest activates the parasympathetic system, slowing them down. This delicate balance helps maintain proper blood circulation depending on activity or mood.

    How Blood Circulates Through the Body

    Every second, human blood travels through an intricate network estimated at more than 60,000 miles in total length, enough to circle the Earth more than twice. This ongoing blood circulation supplies every cell with oxygen and essential nutrients while removing waste products like carbon dioxide.

    The composition of blood is a scientific marvel:

    • Red blood cells carry oxygen from the lungs to tissues.
    • White blood cells defend against infections.
    • Platelets assist with clotting in case of injury.
    • Plasma, the fluid component, transports hormones, proteins, and electrolytes.

    Apart from oxygen delivery, blood circulation has countless side benefits. It helps regulate body temperature, maintain pH balance, and support immune defense. Without this nonstop movement, tissues would be deprived of oxygen and energy, leading to immediate collapse of normal functions.

    Approximately 2.4 million red blood cells are produced in the body every second to keep up with the demand for oxygen transport, a reminder of how dynamic human biology truly is.

    How the Lungs Function

    The lungs are the body’s air exchange centers, responsible for breathing and oxygen transfer. Each day, a person breathes about 20,000 times, allowing nearly 11,000 liters of air to move in and out of the chest cavity. This repetitive action sustains lung function and powers blood oxygenation.

    Air travels through the trachea and bronchi before reaching tiny air sacs called alveoli, where gas exchange occurs. These microscopic sacs, about 300 million in total, allow oxygen to enter the blood while carbon dioxide leaves it. From there, oxygen-rich blood returns to the heart, which pumps it through the body, according to Cleveland Clinic.

    The lungs work closely with the diaphragm, a sheet of muscle that contracts with every breath. When the diaphragm moves downward, the chest cavity expands and draws air inward; when it relaxes, air is pushed out. This simple cycle supports cellular respiration and provides the oxygen needed for energy production.

    Healthy lung function depends largely on clean air, exercise, and hydration. Smoking, pollution, or inactivity can reduce the lungs’ capacity, limiting oxygen intake and placing strain on the heart and overall blood circulation.

    The Connection Between Heart and Lungs

    Though separated anatomically, the heart and lungs operate as one integrated team known as the cardiopulmonary system. When oxygen enters the lungs, it binds to hemoglobin molecules in red blood cells. The heart then pumps these oxygen-loaded cells through arteries, supplying the body with the fuel for life.

    This partnership also works in reverse. As cells use oxygen, they produce carbon dioxide, which the blood transports back to the lungs. There, the waste gas is expelled with each exhale, completing a perfect exchange loop between blood circulation and lung function.

    During physical activity, the heart beats faster and the lungs work harder. The synchrony between them increases oxygen delivery and removes carbon dioxide more quickly, allowing the body to sustain movement and maintain temperature. It’s a striking display of physiological teamwork that scientists continue to study in detail.

    What Happens When Blood Circulation or Lung Function Is Interrupted

    Interruptions in blood circulation or lung function can have immediate and serious effects. If blood flow is blocked, through a clot, heart failure, or vascular disease, oxygen deprivation begins within seconds. Brain cells, which are highly dependent on oxygen, start to deteriorate almost instantly, as per the World Health Organization.

    Similarly, poor lung function prevents efficient oxygen exchange, leading to shortness of breath, fatigue, and reduced oxygen levels in the blood. Chronic respiratory conditions such as asthma, bronchitis, or pulmonary fibrosis compromise blood circulation by limiting the oxygen supplied to the heart and vital organs.

    Scientific research continuously explores ways to protect and restore healthy blood circulation and lung function. Preventive habits, like regular aerobic exercise, a balanced diet, and avoiding tobacco, play measurable roles in keeping these systems efficient.

    Amazing Scientific Facts About Your Heart, Blood, and Lungs

    The human body contains details so intricate that even advanced scientific study continues to uncover new wonders. Here are several fascinating facts supported by anatomy and physiology research:

    • The heart creates enough pressure to squirt blood nearly 30 feet in distance.
    • The body’s blood circulation covers an estimated 60,000 miles of vessel pathways.
    • The lungs weigh about 1.3 kilograms together and contain hundreds of millions of alveoli for gas exchange.
    • Every minute, the heart pumps roughly 5 liters of blood, ensuring each cell receives oxygen.
    • During intense exercise, lung function can increase oxygen intake up to 15 times compared to rest.

    These scientific realities highlight just how active and complex the body truly is, even during sleep.

    Your Body’s Hidden Power: The Unsung Work of the Heart, Blood, and Lungs

    Every moment, the body relies on a perfect sequence of rhythmic motion, the heart beating, the blood circulating, and the lungs breathing.

    Their cooperation keeps oxygen levels balanced and energy flowing to sustain physical and mental activity. Understanding these processes isn’t just fascinating science, it’s a reminder of the natural precision built into human design.

    By supporting healthy blood circulation and lung function through simple daily habits, individuals can strengthen the invisible systems that keep them alive and thriving. Regular movement, hydration, proper rest, and mindful breathing empower the heart and lungs to perform their continuous miracle.

    Behind every heartbeat and breath lies a symphony of life processes, proof of how much the body accomplishes every day without pause.

    Frequently Asked Questions

    1. Why does the heart rate increase during exercise?

    During physical activity, muscles require more oxygen, so the heart pumps faster to circulate oxygen-rich blood more efficiently throughout the body.

    2. Can lung capacity improve with training?

    Yes. Regular aerobic exercise and deep breathing practices can enhance lung function by strengthening respiratory muscles and improving oxygen intake efficiency.

    3. What causes poor blood circulation in healthy adults?

    Factors like prolonged sitting, dehydration, and poor diet can slow blood circulation by reducing vessel elasticity and limiting oxygen flow.

    4. How does stress affect your heart and lungs?

    Stress triggers hormones that raise heart rate and breathing speed. Over time, chronic stress can strain the heart, disrupt healthy blood circulation, and reduce optimal lung function.



    Source link